United Therapeutics Stock Forecast

Sell candidate since Jul 30, 2026 Loss -1.54%

The United Therapeutics Corporation stock price fell by -1.54% on the last day (Friday, 31st Jul 2026) from $525.82 to $517.71. During the last trading day the stock fluctuated 2.23% from a day low at $514.34 to a day high of $525.82. The price has fallen in 6 of the last 10 days and is down by -3.35% for this period. Volume has increased on the last day by 81 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 397 thousand shares were bought and sold for approximately $205.28 million.

The stock lies in the lower of a falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $511.95 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -8.63% during the next 3 months and, with a 90% probability hold a price between $467.75 and $501.06 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

UTHR Signals & Forecast

There are few to no technical positive signals at the moment. The United Therapeutics Corporation stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $525.40 and $539.41. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, July 07, 2026, and so far it has fallen -8.16%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for United Therapeutics Corporation stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $11.48 (2.23%) between high and low. For the last week, the stock has had daily average volatility of 1.80%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (UTHR) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect United Therapeutics Corporation to open at $519.29, and during the day (based on 14 day Average True Range), to move between $511.86 and $523.56, which gives a possible trading interval of +/-$11.70 (+/-2.29%) up or down from last closing price. If United Therapeutics Corporation takes out the full calculated possible swing range there will be an estimated 2.29% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $536.59, some $18.88 (3.65%) from the current price of $517.71, our system finds the risk reward not very attractive.

Is United Therapeutics Corporation stock A Buy?

United Therapeutics Corporation holds several negative signals and is within a falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.345 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $519.29 ( 0.305%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk